OmicsBank
Provides clinical data infrastructure for healthcare, life sciences, and frontier AI labs expanding access to omics and clinical datasets.
Overview
OmicsBank builds clinical data infrastructure intended to support healthcare organizations, life sciences companies, and frontier AI labs. Its work centers on expanding access to omics and clinical datasets for users developing, researching, or deploying data-driven health and AI applications. The company’s positioning is differentiated by its focus on global expansion of clinical data infrastructure across both biomedical and AI research markets. OmicsBank raised a seed round reported at roughly $2 million in August 2026 to support that expansion.
Funding History
OmicsBank Raises $2.25M to Expand Clinical Data Infrastructure Globally for Healthcare, Life Sciences, and Frontier AI Labs
Frequently Asked Questions
- How much funding does AI Funding track for OmicsBank?
- AI Funding tracks $2M for OmicsBank across 1 funding round in this database.
- What does OmicsBank do?
- OmicsBank builds clinical data infrastructure intended to support healthcare organizations, life sciences companies, and frontier AI labs. Its work centers on expanding access to omics and clinical datasets for users developing, researching, or deploying data-driven health and AI applications. The company’s positioning is differentiated by its focus on global expansion of clinical data infrastructure across both biomedical and AI research markets. OmicsBank raised a seed round reported at roughly $2 million in August 2026 to support that expansion.
- Where is OmicsBank headquartered?
- OmicsBank is headquartered in San Francisco, CA.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.